PAPER Hu Y, Cho M, Sachdev P, Dage J, Hendrix S, Hansson O, Bateman RJ, Hampel H
SEARCH RESULTS
340318 RESULTS
PAPER Benatar M, Macklin EA, Malaspina A, Rogers ML, Hornstein E, Lombardi V, Renfrey D, Shepheard S, Magen I, Cohen Y, Granit V, Statland JM, Heckmann JM, Rademakers R, McHutchison CA, Petrucelli L, McMillan CT, Wuu J, CReATe Consortium PGB1 Study Investigators
Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis.
EBioMedicine. 2024 Oct;108:105323. Epub 2024 Sep 12 PubMed.PAPER Chen Y, Holtzman DM
New insights into innate immunity in Alzheimer's disease: from APOE protective variants to therapies.
Trends Immunol. 2024 Oct;45(10):768-782. Epub 2024 Sep 14 PubMed.PAPER Tumati S, Herrmann N, Perin J, Rosenberg PB, Lerner AJ, Mintzer J, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Shade D, Lanctôt KL
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2.
Int Psychogeriatr. 2024 Sep 19;:1-13. PubMed.PAPER Cano A, Capdevila M, Puerta R, Arranz J, Montrreal L, de Rojas I, García-González P, Olivé C, García-Gutiérrez F, Sotolongo-Grau O, Orellana A, Aguilera N, Ramis M, Rosende-Roca M, Lleó A, Fortea J, Tartari JP, Lafuente A, Vargas L, Pérez-Cordón A, Muñoz N, Sanabria Á, Alegret M, Morató X, Tárraga L, Fernández V, Marquié M, Valero S, Alcolea D, Boada M, Ruiz A
Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic.
EBioMedicine. 2024 Oct;108:105345. Epub 2024 Sep 18 PubMed.PAPER Karabag D, Heneka MT, Ising C
The putative contribution of cellular senescence to driving tauopathies.
Trends Immunol. 2024 Oct;45(10):837-848. Epub 2024 Sep 20 PubMed.PAPER Summers RA, Fagiani F, Rowitch DH, Absinta M, Reich DS
Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine.
Trends Immunol. 2024 Oct;45(10):799-813. Epub 2024 Sep 21 PubMed.PAPER Sharma P, Sharma S, Yadav Y, Shukla P, Sagar R
Current pharmacophore based approaches for the development of new anti-Alzheimer's agents.
Bioorg Med Chem. 2024 Nov 1;113:117926. Epub 2024 Sep 13 PubMed.PAPER Castelo-Branco G, Kukanja P, Guerreiro-Cacais AO, Rubio Rodríguez-Kirby LA
Disease-associated oligodendroglia: a putative nexus in neurodegeneration.
Trends Immunol. 2024 Oct;45(10):750-759. Epub 2024 Sep 24 PubMed.PAPER Terrabuio E, Constantin G
APOE4 affects neutrophil-microglia crosstalk in Alzheimer's disease.
Trends Immunol. 2024 Oct;45(10):726-728. Epub 2024 Sep 24 PubMed.PAPER Narendra DP, Youle RJ
The role of PINK1-Parkin in mitochondrial quality control.
Nat Cell Biol. 2024 Oct;26(10):1639-1651. Epub 2024 Oct 2 PubMed.PAPER Schwartz M, Colaiuta SP
Boosting peripheral immunity to fight neurodegeneration in the brain.
Trends Immunol. 2024 Oct;45(10):760-767. PubMed.PAPER Gehlot P, Pathak R, Kumar S, Choudhary NK, Vyas VK
A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD).
Bioorg Med Chem. 2024 Nov 1;113:117925. Epub 2024 Sep 14 PubMed.PAPER Pascoal TA, Aguzzoli CS, Lussier FZ, Crivelli L, Suemoto CK, Fortea J, Rosa-Neto P, Zimmer ER, Ferreira PC, Bellaver B
Insights into the use of biomarkers in clinical trials in Alzheimer's disease.
EBioMedicine. 2024 Oct;108:105322. Epub 2024 Oct 3 PubMed.PAPER Carmona-Iragui M, O'Connor A, Llibre-Guerra J, Lao P, Ashton NJ, Fortea J, Sánchez-Valle R
Clinical and research application of fluid biomarkers in autosomal dominant Alzheimer's disease and Down syndrome.
EBioMedicine. 2024 Oct;108:105327. Epub 2024 Oct 3 PubMed.Current Filters
No filters selected